BMS-243117 | m-entrepreneurship.com

Product Name :
BMS-243117

Search keywords :
BMS-243117

drugId :
null

Target Vo:
Tyrosine-protein kinase LCK

Target Vo Short Name :
LCK

Moa_Name:
Tyrosine-protein kinase LCK inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Bristol-Myers Squibb Company

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PRMT6 Antibody (YA685)
BRCA1 Antibody
IL-6 Antibody (YA724): IL-6 Antibody (YA724) is a non-conjugated and Mouse origined monoclonal antibody about 24 kDa, targeting to IL-6. It can be used for WB,IHC-P,ICC,ELISA assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts